TOKYO, April 6, 2015 /PRNewswire/ -- Astellas
("Astellas,") (Tokyo: 4503) today
announced that Dr. Shontelle Dodson
has been named vice president, Medical Excellence, Medical Affairs.
Dodson will be located at Astellas' global headquarters for its
Medical and Development functions in Northbrook, Ill., USA, and will report to Dr.
Charlotte Kremer, executive vice
president, Medical Affairs.
Dodson will oversee the Medical Excellence functions within the
company's Medical Affairs organization, including Global Medical
Communications, Scientific Publications, Health Economics and
Outcomes Research, and Medical Affairs Research and Grants. As a
key direct report to Kremer, she will play an instrumental role in
leading key functional groups that provide support and service
across the therapeutic areas served by the company's Medical
Affairs organization.
"Astellas couldn't be more pleased to have someone like
Shontelle take on this important role in building a best in class
Medical Affairs organization," said Kremer. "Her diverse experience
across the different facets of medical affairs in industry roles
and prior work in clinical settings will offer the insights needed
to help Astellas continue to address the unmet needs of our
patients."
Dodson joined Astellas in 2012 and, since that time, has led the
Health Economics and Clinical Outcomes Research team in the
Americas. Under her leadership, that team has pioneered multiple
real world data projects, including two national registries in
prostate cancer and overactive bladder, as well as partnered
research with leading managed care and academic organizations.
Dodson holds a doctorate in pharmacy from Mercer University School of Pharmacy and completed
a postdoctoral residency at the Department of Veterans Affairs
Medical Center in Nashville,
Tennessee.
About Astellas Pharma Inc.
Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company
dedicated to improving the health of people around the world
through the provision of innovative and reliable pharmaceuticals.
Astellas has approximately 18,000 employees worldwide. The
organization is committed to becoming a global category leader in
Urology, Immunology (including Transplantation) and Infectious
diseases, Oncology, Neuroscience and Diabetes Mellitus (DM)
Complications and Kidney diseases. For more information on Astellas
Pharma Inc., please visit the company website at
www.astellas.com/en.
Logo - http://photos.prnewswire.com/prnh/20140416/84970
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/astellas-appoints-shontelle-dodson-to-lead-medical-excellence-function-300060939.html
SOURCE Astellas Pharma Inc.